Daily as of 3 Nov 16:00 ET
- Price
- below both $7.35 vs 50 $8.70 / 200 $13.82
- Projection
- No cross projected
- Test
- No active test
- Last cross
- ๐Death cross 11 May 2026 ยท projected 29 bars out
Olema Pharmaceuticals (OLMA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.
The 50 SMA has sat below the 200 on the daily since May 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 11 May 2026 | ๐Death steep | daily | 29 bars out | Not tested |
| 17 Mar 2026 | ๐Death | 4-hour | 24 bars out | Not tested |
| week of 22 Dec 2025 | ๐จGolden moderate | weekly | 7 bars out | Not tested |
| 11 Sep 2025 | ๐จGolden moderate | daily | 20 bars out | Not tested |
| 17 Jul 2025 | ๐จGolden | 4-hour | 17 bars out | โ |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.